CAR T Cells Infiltrate Brain, Target Tumors.
A single dose of peripherally infused CAR T cells cleared antigen-expressing tumor cells in patients with glioblastoma, a 10-person trial found. However, the cells also triggered an immunosuppressive microenvironment, and the target antigen, EGFR variant III, wasn't expressed uniformly in patients' tumors.